Skip to main content
. 2021 Sep 27;8(10):e633–e651. doi: 10.1016/S2352-3018(21)00152-1

Table 2.

Number of deaths, incident cases, and prevalent cases (thousands) globally and by GBD super-region, for both sexes combined, in 1990, 2000, 2010, and 2019

1990
1999
2009
2019
Males Females Males Females Males Females Males Females
Global
Deaths 171 (135–221) 165 (121–230) 656 (493–850) 785 (566–1042) 658 (580–776) 796 (687–956) 435 (399–500) 428 (383–502)
Incident cases 920 (781–1060) 1140 (917–1370) 1450 (1240–1740) 1740 (1460–2140) 1110 (1020–1260) 1290 (1130–1490) 991 (878–1110) 999 (862–1170)
Prevalent cases 3870 (3350–4400) 3960 (3400–4550) 11 100 (10 300–11 900) 13 400 (12 300–14 400) 13 400 (12 400–14 600) 15 900 (15 300–16 700) 16 800 (15 600–18 400) 20 100 (19 300–20 900)
Central Europe, eastern Europe, and central Asia
Deaths 4·56 (4·5–4·62) 1·32 (1·3–1·34) 12·7 (12·5–12·9) 3·16 (3·12–3·2) 18·5 (18·3–18·7) 6·69 (6·59–6·79) 19·3 (19–19·7) 8·39 (8·26–8·52)
Incident cases 11 (8·62–13·7) 2·77 (2·16–3·6) 29·2 (18·8–63·2) 10·8 (6·3–22) 45·8 (38·7–55·3) 22·4 (18·4–27·2) 112 (88·1–141) 53 (42·4–68·7)
Prevalent cases 72·6 (47·9–108) 16·2 (11·1–23·5) 170 (114–252) 51·5 (31·8–83·3) 333 (232–480) 145 (98·1–212) 1020 (837–1270) 520 (420–654)
High income
Deaths 34·8 (34·5–35) 5·22 (5·17–5·28) 21·2 (21·1–21·4) 6·66 (6·61–6·71) 13·6 (13·5–13·6) 4·98 (4·94–5·02) 9·89 (9·79–9·99) 3·5 (3·46–3·54)
Incident cases 76·1 (55·6–98·9) 23·4 (15·7–33·2) 55·4 (39·6–70·2) 26·9 (17·9–35·8) 58·9 (37·8–82·5) 25·6 (16–36·3) 83·7 (49–118) 34·6 (19·9–50·6)
Prevalent cases 1080 (698–1520) 227 (137–338) 1250 (733–1850) 369 (210–555) 1570 (900–2280) 569 (322–827) 2060 (1210–2960) 811 (479–1160)
Latin America and Caribbean
Deaths 12·7 (11·9–14·2) 5·13 (4·31–6·7) 30·1 (27–34·3) 17·5 (14·2–21·5) 29·9 (28·3–32·4) 17·8 (16–20) 27·0 (25·5–29·4) 14·9 (13·4–17)
Incident cases 59·2 (50·8–67·9) 34 (27·3–41·8) 64·1 (54·2–72·1) 43·3 (35·6–49·4) 72·3 (65–79·5) 42·9 (36·5–49·8) 89·9 (78·5–107) 44·8 (38–52·8)
Prevalent cases 247 (188–313) 115 (84·8–149) 505 (401–621) 306 (259–349) 771 (665–889) 483 (426–537) 1200 (1030–1410) 686 (603–772)
North Africa and Middle East
Deaths 0·406 (0·183–0·969) 0·313 (0·145–0·725) 1·87 (0·971–3·92) 1·78 (0·909–3·62) 3·67 (2·04–7·68) 3·6 (2·17–6·72) 4·72 (2·55–9·97) 4·72 (2·88–9·12)
Incident cases 1·98 (0·765–4·88) 2 (0·62–5·2) 5·69 (2·89–12·4) 5·72 (2·82–10·3) 7·7 (4·01–16·5) 7·44 (3·76–13·8) 11·8 (5·12–30) 12·3 (4·51–34)
Prevalent cases 9·23 (5·44–18) 7·16 (3·34–16·8) 31·4 (16–66·5) 31·9 (14·3–62·7) 60·1 (33·8–126) 58 (33–102) 103 (54·9–214) 101 (49·4–206)
South Asia
Deaths 0·812 (0·445–1·71) 0·619 (0·43–1·04) 46·5 (34·3–64·6) 29·8 (22·5–40·7) 81 (69·8–96·9) 64·8 (54·2–77·8) 28·8 (22·8–47·3) 23·2 (18·8–35)
Incident cases 19 (7·51–38·8) 9·64 (3·89–19·4) 187 (148–231) 136 (109–167) 59·8 (38·3–91·2) 44·8 (29·1–68·3) 50·1 (28–94·7) 37·8 (22·1–66·5)
Prevalent cases 41·2 (23·6–74) 19·5 (11·4–34·3) 1100 (970–1250) 729 (644–822) 1100 (978–1290) 805 (718–911) 1130 (975–1440) 805 (700–984)
Southeast Asia, east Asia, and Oceania
Deaths 3·28 (1·84–4·56) 1·73 (1·04–2·23) 41·2 (32·5–46·7) 21·6 (17·4–25·1) 49·1 (44·8–55·3) 26·5 (22·4–32·5) 53·8 (47·5–64·1) 26·0 (21·4–33·2)
Incident cases 69·3 (46·6–95·4) 30·9 (20·7–43·8) 77·4 (66·3–98) 48·5 (38·1–60·1) 110 (94·1–138) 54·6 (46·2–66·6) 120 (92·9–164) 49·2 (38·8–65·9)
Prevalent cases 134 (100–174) 58·4 (43·8–76·8) 769 (616–958) 441 (358–540) 1210 (941–1640) 707 (578–871) 1540 (1170–2260) 839 (675–1100)
Sub-Saharan Africa
Deaths 115 (80–163) 151 (107–214) 502 (363–669) 704 (500–945) 462 (395–566) 672·0 (575–817) 292 (254–353) 348 (304–414)
Incident cases 683 (526–849) 1040 (805–1270) 1030 (835–1300) 1470 (1200–1840) 760 (658–900) 1090 (949–1280) 524 (436–640) 767 (636–930)
Prevalent cases 2290 (1900–2710) 3520 (2930–4070) 7320 (6480–8080) 11500 (10300–12500) 8390 (7950–8930) 13 200 (12700–13700) 9740 (9210–10 300) 16 300 (15 600–16 900)

Data in parentheses are 95% uncertainty intervals. GBD=Global Burden of Diseases, Injuries, and Risk Factors Study.